Evaluation of CD4+CD161+CD196+ and CD4+IL-17+ Th17 cells in the peripheral blood of young patients with Hashimoto's thyroiditis and Graves' disease;Analiza komórek CD4+CD161+CD196+ i CD4+IL-17+ Th17 we krwi obwodowej u młodocianych z zapaleniem tarczycy typu Hashimoto i choroba̧ Gravesa-Basedowa

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 18, Issue 3, 2012, Pages 89-95

  Bossowski, Artur ^a   Moniuszko, Marcin ^b   Idzḱowska, Ewelina ^a   Dab̧rowska, Milena ^c   Jeznach, Marta ^b   Sawicka, Beata ^a   Borysewicz Sanćzyk, Hanna ^a   Bossowska, Anna ^d   Rusak, Małgorzata ^c   Bodzenta uŁkaszyk, Anna ^b  

^a Klinika Pediatrii   (Poland)

^b Uniwersytetu Medycznego w Bia ymstoku   (Poland)

^c Uniwersytetu Medycznego W Bia ymstoku   (Poland)

^d NONE   (Poland)

Author keywords

Graves' disease; Hashimoto's thyroiditis; Th17

Indexed keywords

CD161 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CYTOKINE; FLUOROCHROME; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; MONOCLONAL ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNE RESPONSE; PATHOGENESIS; PHENOTYPE; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ADOLESCENT; ANTIGENS, CD4; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; INTERLEUKIN-17; LYMPHOCYTE COUNT; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; RECEPTORS, CCR6; TH17 CELLS; YOUNG ADULT;

EID: 84904844495     PISSN: 1234625X     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hasham A, Tomer Y. Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol Res. 2012 (poza drukiem).
2. Phenekos C, Vryonidou A, Gritzapis AD, i wsp. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation. 2004;11:209-213. (Pubitemid 38916092)
3. Marwaha AK, Leung NJ, McMurchy AN, Levings MK. Th17 Cells in Autoimmunity and Immunodeficiency: Protective or pathogenic? Front Immunol. 2012;3:129.
4. Cooke A. Th17 cells in inflammatory conditions. Rev Diabet Stud. 2006;3:72-75.
5. Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun. 2008;31:252-256.
6. Damsker JM, Hansen AM, Caspi RR. Th1 and Th17 cells: Adversaries and collaborators. Ann N Y Acad Sci. 2010;1183:211-221.
7. Hirota K, Martin B, Veldhoen M. Development, regulation and functional capacities of Th17 cells. Semin Immunopathol. 2010;32:3-16.
8. Annunziato F, Romagnani S. Do studies in humans better depict Th17 cells? Blood. 2009;114:2213-2219.
9. Maggi L, Santarlasci V, Capone M, i wsp. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol. 2010;40:2174-2181.
10. Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol. 2007;19:652-657. (Pubitemid 350236805)
11. Paradowska A, Maśliński W, Grzybowska-Kowalczyk A, Łacki J. The function of interleukin 17 in the pathogenesis of rheumatoid arthritis. Arch Immunol Ther Exp (Warsz). 2007;55:329-334.
12. Wong CK, Lit LC, Tam LS, i wsp. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in autoimmunity. Clin Immunol. 2008;127:385-393.
13. Figueroa-Vega N, Alfonso-Perez M, Benedicto I, i wsp. Increased circulating proinflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2010;95:953-962.
14. Zhou J, Bi M, Fan C, Song X, i wsp. Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism. Clin Exp Med. 2011;12:39-46.
15. Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease, Thyroid. 2009;19:495-501.
16. Awasthi A, Kuchroo VK. IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation. Nat Immunol. 2009;10:568-570.
17. Shi G, Cox CA, Vistica BP. Phenotype switching by Inflammation-Inducing Polarized Th17 Cells, but not by Th1 Cells. J Immunol. 2008;181:7205-7213.
18. Marazuela M, García-López MA, Figueroa-Vega N, i wsp. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab. 2006;91:3639-3646. (Pubitemid 44402149)
19. Zhou L, Lopes JE, Chong MM, i wsp. TGF-b-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature. 2008;453:236-240. (Pubitemid 351667978)
20. Korn T, Mitsdoerffer M, Croxford AL, i wsp. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci USA. 2008;25:18460-18465.
21. Guclu F, Ozmen B, Kirmaz C, i wsp. Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with L-thyroxine. Eur. Cytokine Netw. 2009;20:27-32.
22. Romaldini JH, Biancalana MM, Figueiredo DI, i wsp. Effect of L-thyroxine administration on antithyroid antibody levels, lipid profile, and thyroid volume in patients with Hashimoto's thyroiditis. Thyroid. 1996;6:183-188. (Pubitemid 26279409)
23. Chiovato L, Lapi P, Mariotti S, i wsp. Simultaneous expression of thyroid peroxidase and human leukocyte antigen-DR by human thyroid cells: modulation by thyrotropin, thyroid-stimulating antibody, and interferon-gamma. J Clin Endocrinol Metab. 1994;79:653.
24. Sivamani RK, Goodarzi H, Garcia MS, i wsp. Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring. Clin Rev Allergy Immunol. 2012 [Epub ahead of print].
25. Toussirot E. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflamm Allergy Drug Targets. 2012;11:159-168.